Nonionic intravenous contrast agent does not cause clinically significant artifacts to 18F-FDG PET/CT in patients with lung cancer

Annals of Nuclear Medicine

Volumn 21, Issue 10, 2007, Pages 585-592

  An, Young Sil ^a   Sheen, Seung S ^a   Oh, Y J ^a   Hwang, Sung C ^a   Yoon, Joon Kee ^a  

^a Ajou University School of Medicine   (South Korea)

Author keywords

18F FDG PET CT; Contrast related artifact; Intravenous contrast; Lung cancer; Nodal stage

Indexed keywords

FLUORODEOXYGLUCOSE F 18; IODINATED CONTRAST MEDIUM; IOMEPROL; NONIONIC CONTRAST MEDIUM;

ADULT; AGED; AORTA; ARTICLE; ARTIFACT; BONE MARROW; CANCER STAGING; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG UPTAKE; FEMALE; HUMAN; IMAGE DISPLAY; LIVER; LUNG CANCER; LYMPH NODE; MALE; METASTASIS; MUSCLE; PRIORITY JOURNAL; PROSPECTIVE STUDY;

ADULT; AGED; AGED, 80 AND OVER; ARTIFACTS; CONTRAST MEDIA; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; IOPAMIDOL; LUNG; LUNG NEOPLASMS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; SUBTRACTION TECHNIQUE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 37349086758     PISSN: 09147187     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12149-007-0066-3     Document Type: Article

References (27)

1. R Bar-Shalom L Guralnik M Tsalic M Leiderman A Frenkel D Gaitini 2005 The additional value of PET/CT over PET in FDG imaging of oesophageal cancer Eur J Nucl Med Mol Imaging 32 918 24
2. T Beyer DW Townsend T Brun PE Kinahan M Charron R Roddy 2000 A combined PET/CT scanner for clinical oncology J Nucl Med 41 1369 79
3. YK Chen HJ Ding CT Su YY Shen LK Chen AC Liao 2004 Application of PET and PET/CT imaging for cancer screening Anticancer Res 24 4103 8
4. 18F-FDG PET, in-line PET/CT, and software fusion for restaging of recurrent colorectal cancer J Nucl Med 46 587 95
5. C Nanni D Rubello S Fanti M Farsad V Ambrosini L Rampin 2006 Role of 18F-FDG-PET and PET/CT imaging in thyroid cancer Biomed Pharmacother 60 409 13
6. S Yuan Y Yu KS Chao Z Fu Y Yin T Liu 2006 Additional value of PET/CT over PET in assessment of locoregional lymph nodes in thoracic esophageal squamous cell cancer J Nucl Med 47 1255 9
7. GW Goerres GK von Schulthess HC Steinert 2004 Why most PET of lung and head-and-neck cancer will be PET/CT J Nucl Med 45 66S 71S
8. G Antoch J Stattaus AT Nemat S Marnitz T Beyer H Kuehl 2003 Non-small cell lung cancer: dual-modality PET/CT in preoperative staging Radiology 229 526 33
9. D Lardinois W Weder TF Hany EM Kamel S Korom B Seifert 2003 Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography N Engl J Med 348 2500 7
10. LE Albertyn 1989 Rationales for use of intravenous contrast medium in computed tomography Australas Radiol 33 29 33
11. G Antoch LS Freudenberg T Beyer A Bockisch JF Debatin 2004 To enhance or not to enhance? 18F-FDG and CT contrast agents in dual-modality 18F-FDG PET/CT J Nucl Med 45 56S 65S
12. G Anotoch LS Freudenberg T Egelhof J Stattaus W Jentzen JF Debatin 2002 Focal tracer uptake: a potential artifact in contrast-enhanced dual-modality PET/CT scans J Nucl Med 43 1339 42
13. G Anotoch LS Freudenberg J Stattaus W Jentzen SP Mueller JF Debatin 2002 Whole-body positron emission tomography-CT: optimized CT using oral and IV contrast materials AJR Am J Roentgenol 179 1555 60
14. T Beyer G Antoch S Muller T Egelhof LS Freudenberg J Debatin 2004 Acquisition protocol considerations for combined PET/CT imaging J Nucl Med 45 25S 35S
15. Y Nakamoto BB Chin DL Kraitchman LP Lawler LT Marshall RL Wahl 2003 Effects of nonionic IV contrast agents at PET/CT imaging: phantom and canine studies Radiology 227 817 24
16. BT Kim KS Lee SS Shim JY Choi OJ Kwon H Kim 2006 Stage T1 Non-small cell lung cancer: preoperative mediastinal nodal staging with integrated FDG PET/CT - a prospective study Radiology 241 501 9
17. SS Gambhir J Czernin J Schwimmer DH Silverman RE Coleman ME Phelps 2001 A tabulated summary of the FDG literature J Nucl Med 42 1S 93S
18. H van Tinteren OS Hoekstra EF Smit JH van den Bergh AJ Schreurs RA Stallaert 2002 Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-call lung cancer: the PLUS multicentre randomized trial Lancet 359 1388 93
19. J Czernin H Schelbert 2004 PET/CT imaging: facts, opinions, hopes, and questions J Nucl Med 45 1S 3S
20. DW Townsend T Beyer PE Kinahan T Brun R Roddy R Nutt 1998 The SMART scanner: a combined PET/CT tomography for clinical oncology IEEE Nucl Sci Symp Conf Rec 2 1170 4
21. RJ Alfidi J Haaga TF Meaney WJ [tmp] MacIntyre L Gonzalez R Tarar 1975 Computed tomography of the thorax and abdomen: a preliminary report Radiology 117 257 64
22. FA Beurgener DJ Hamlin 1981 Intravenous contrast enhancement in computed tomography of pelvic malignancies Rofo 134 656 61
23. MJ Kormano MJ Goske DJ Hamlin 1981 Attenuation and contrast enhancement of gynecologic organs and tumors in CT Eur J Radiol 1 307 11
24. MR Violante PB Dean 1980 Improved detectability of VX2 carcinoma in the rabbit liver with contrast enhancement in computed tomography Radiology 134 237 9
25. PR Garrett SL Meshkov GS Perlmutter 1984 Oral contrast agents in CT of the abdomen Radiology 153 545 6
26. YY Yat WS Chan YM Tam P Vernon S Wong M Coel 2005 Application of intravenous contrast in PET/CT: does it really introduce significant attenuation correction error? J Nucl Med 46 283 91
27. O Mawlawi JJ Erasmus RF Munden T Pan AE Knight HA Macapinlac 2006 Quantifying the effect of IV contrast media on integrated PET/CT: clinical evaluation AJR Am J Roentgenol 186 308 19